- Home
- IPCX vs GEVO Comparison
IPCX vs GEVO Comparison
Compare IPCX & GEVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPCX
- GEVO
- Stock Information
- Founded
- IPCX 2024
- GEVO 2005
- Country
- IPCX United States
- GEVO United States
- Employees
- IPCX N/A
- GEVO N/A
- Industry
- IPCX
- GEVO Major Chemicals
- Sector
- IPCX
- GEVO Industrials
- Exchange
- IPCX NYSE
- GEVO Nasdaq
- Market Cap
- IPCX 348.5M
- GEVO 354.6M
- IPO Year
- IPCX 2025
- GEVO 2011
- Fundamental
- Price
- IPCX $10.18
- GEVO $1.35
- Analyst Decision
- IPCX
- GEVO Buy
- Analyst Count
- IPCX 0
- GEVO 2
- Target Price
- IPCX N/A
- GEVO $7.58
- AVG Volume (30 Days)
- IPCX 4.8K
- GEVO 3.0M
- Earning Date
- IPCX 01-01-0001
- GEVO 08-11-2025
- Dividend Yield
- IPCX N/A
- GEVO N/A
- EPS Growth
- IPCX N/A
- GEVO N/A
- EPS
- IPCX N/A
- GEVO N/A
- Revenue
- IPCX N/A
- GEVO $42,034,000.00
- Revenue This Year
- IPCX N/A
- GEVO $1,022.79
- Revenue Next Year
- IPCX N/A
- GEVO $12.26
- P/E Ratio
- IPCX N/A
- GEVO N/A
- Revenue Growth
- IPCX N/A
- GEVO 145.38
- 52 Week Low
- IPCX $10.07
- GEVO $0.48
- 52 Week High
- IPCX $11.06
- GEVO $3.39
- Technical
- Relative Strength Index (RSI)
- IPCX N/A
- GEVO 44.97
- Support Level
- IPCX N/A
- GEVO $1.32
- Resistance Level
- IPCX N/A
- GEVO $1.58
- Average True Range (ATR)
- IPCX 0.00
- GEVO 0.08
- MACD
- IPCX 0.00
- GEVO -0.03
- Stochastic Oscillator
- IPCX 0.00
- GEVO 12.43
About IPCX INFLECTION POINT ACQUISITION CORP
Inflection Point Acquisition Corp III is a special-purpose acquisition company.
About GEVO Gevo Inc.
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment.